MODIFICATION TO SYNCHRON LX 20 CLINICAL CHEMISTRY SYSTEM— 510(k) K011213

Name: FDA 510(k) clearance K011213
Creator: U.S. Food and Drug Administration
Published: 2001-05-16

Substantially Equivalent

Beckman Coulter, Inc.

FDA 510(k) clearance K011213 for MODIFICATION TO SYNCHRON LX 20 CLINICAL CHEMISTRY SYSTEM, Substantially Equivalent on 2001-05-16. Applicant: Beckman Coulter, Inc.. Device class: 2.

Clearance details

Applicant: Beckman Coulter, Inc.
Product code: Code JGS
Device class: Class 2
Regulation: 21 CFR 862.1665
Advisory panel: Clinical Chemistry
Date received: 2001-04-20
Decision date: 2001-05-16
Decision: Substantially Equivalent
Clearance type: Special
Location: Brea, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JGS

view all

K252475 — ABL90 FLEX PLUS System2026-05-01
K230275 — i-STAT CG8+ cartridge with the i-STAT 1 System2023-10-27
K222438 — A-LYTE® Integrated Multisensor (IMT Na K Cl)2023-07-25
K220977 — ISE Reagents, Glucose, CRP Latex, DxC 500 AU Clinical Chemistry Analyzer2023-07-20
K213486 — GLP systems Track2022-03-10

More clearances from Beckman Coulter, Inc.

view all

K252169 — Access BNP II2026-03-24
K254059 — Access anti-HBc IgM2026-03-13
K253687 — Access anti-HBc Total2026-02-19
K251995 — Access anti-HAV IgM2026-01-27
K250588 — Access Rubella IgG2025-11-17

Adverse events under product code JGS

product code JGS

Malfunction: 535
Total: 535

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.